icon

HIV Genotyping & Drug Resistance

Sequencing-focused HIV-1 assay solutions for laboratories that need targeted genotyping, drug resistance insights, and flexible Sanger or NGS workflow support.

Genotyping Through Sequencing

DeepChek® HIV-1 assay portfolio

Genient Technologies offers HIV-1 genotyping and drug resistance solutions aligned with DeepChek® assays from ABL Diagnostics. The portfolio covers core HIV-1 genomic regions such as protease, reverse transcriptase, integrase, envelope targets, gag, and whole genome workflows.

HIV-1 genotyping Drug resistance support Sanger / NGS compatible
HIV genotyping sequencing solutions

HIV Assay Options

Select from focused HIV-1 genotyping assays or broader sequencing panels depending on the target region, workflow, and laboratory requirement.

HIV-1 Full PR RT INT
Now Available
HIV-1 Full PR/RT/INT Drug Resistance

End-to-end whole pol gene sequencing option covering protease, reverse transcriptase, and integrase regions for broader HIV-1 resistance analysis.

View Details arrow
Protease Reverse Transcriptase
CE-IVD RUO
Protease / Reverse Transcriptase

Targets the PR and RT regions to support antiretroviral susceptibility interpretation for PI, NRTI, and NNRTI drug classes.

View Details arrow
Integrase genotyping
CE-IVD RUO
Integrase Genotyping & Drug Resistance

Amplifies the HIV-1 integrase region to help laboratories assess resistance-associated mutations in integrase-focused workflows.

View Details arrow
Whole Genome HIV-1 Genotyping
CE-IVD RUO
Whole Genome HIV-1 Genotyping

Supports whole-genome HIV-1 amplification from clinical sample RNA for expanded mutation and antiviral resistance-associated analysis.

View Details arrow
V3 Loop Tropism
RUO
V3 Loop / Tropism

Focused HIV-1 envelope-region assay option for laboratories requiring V3 loop and tropism related genotyping support.

View Details arrow
GP41 GP120 genotyping
RUO
GP41 / GP120 Genotyping

Envelope-targeted assay option for HIV-1 gp41 and gp120 genotyping and drug resistance research workflows.

View Details arrow
GAG genotyping
RUO
GAG Genotyping & Drug Resistance

Research-use HIV-1 gag-region assay option for laboratories extending genotyping beyond the standard PR, RT, and INT targets.

View Details arrow
Full RT PR INT drug resistance
RUO
Full RT/PR/INT Drug Resistance

RUO option for combined reverse transcriptase, protease, and integrase region sequencing in HIV-1 drug resistance workflows.

View Details arrow
HIV sequencing support
Support
Need Help Selecting a Panel?

Our team can help map your laboratory workflow, target region, sequencing platform, and regulatory requirement to the right HIV genotyping solution.

Talk To Us arrow

Workflow Fit

Designed for molecular laboratories that need reliable assay options across sample preparation, sequencing, analysis, and reporting touchpoints.

Targeted Amplification

Assay choices cover focused genes and broader regions including PR, RT, INT, envelope targets, gag, pol, and whole genome options.

Sanger or NGS Alignment

Portfolio options are positioned for sequencing-based HIV-1 genotyping, with support for lab workflows using Sanger or next-generation sequencing.

Analysis Support

DeepChek® HIV software support can help laboratories interpret sequencing data and structure reporting around genotyping and resistance findings.

Why Genient for HIV Genotyping?

  • Curated HIV-1 genotyping and drug resistance assay portfolio for clinical and research laboratory needs.
  • Coverage across focused and expanded target regions, helping labs choose the right panel for each workflow.
  • Application and scientific support from a team working across genomics, molecular diagnostics, and life science solutions.

Bring HIV-1 sequencing into your lab workflow

Speak with Genient Technologies for assay selection, availability, workflow fit, and implementation support.

Contact Us